Compositions comprising constituents, derivatives or extracts of cannabis
US-2024415913-A1 · Dec 19, 2024 · US
A Nicotine Oral Delivery Product
US2023180817A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2023180817-A1 |
| Application number | US-202117921538-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 27, 2021 |
| Priority date | Apr 28, 2020 |
| Publication date | Jun 15, 2023 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A nicotine oral delivery product includes a composition enclosed in a water insoluble pouch, wherein the pouch is permeable for saliva and dissolved compounds of the composition, the composition including a source of nicotine and a cellulose or cellulose derivative, wherein the cellulose or cellulose derivative is in granular form. A method of making the nicotine oral delivery product is also provided.
First claim
Opening claim text (preview).
1 . A nicotine oral delivery product comprising a composition enclosed in a water insoluble pouch, wherein said pouch is permeable for saliva and dissolved compounds of the composition, the composition comprising a source of nicotine and a cellulose or cellulose derivative, wherein the cellulose or cellulose derivative is in granular form. 2 . The nicotine oral delivery product according to claim 1 , wherein the cellulose or cellulose derivative is a cellulose derivative. 3 . The nicotine oral delivery product according to claim 2 , wherein the cellulose derivative is a cellulose ether. 4 . The nicotine oral delivery product according to claim 2 , wherein the cellulose derivative is carboxymethylcellulose. 5 . The nicotine oral delivery product according to claim 1 , wherein the source of nicotine provides 0.1 to 30 mg of nicotine per nicotine oral delivery product. 6 . The nicotine oral delivery product according to claim 5 , wherein the source of nicotine is at least one selected from the group of tobacco, nicotine salt, nicotine base, stabilised nicotine and combinations thereof. 7 . The nicotine oral delivery product according to claim 1 , wherein the source of nicotine is at least one selected from the group of nicotine salt, nicotine base, stabilised nicotine and combinations thereof. 8 . The nicotine oral delivery product according to claim 1 , wherein the source of nicotine is stabilised nicotine. 9 . The nicotine oral delivery product according to claim 8 , wherein the source of nicotine is nicotine polacrilex. 10 . The nicotine oral delivery product according to claim 1 , wherein the composition further comprises an additional cellulose or additional cellulose derivative. 11 . The nicotine oral delivery product according to claim 10 , wherein the additional cellulose or additional cellulose derivative is cellulose. 12 . The nicotine oral delivery product according to claim 10 , wherein the additional cellulose or additional cellulose derivative is microcrystalline cellulose. 13 . The nicotine oral delivery product according to claim 10 , wherein the additional cellulose or additional cellulose derivative is in powder form. 14 . A method of making the nicotine oral delivery product according to claim 1 , the method comprising introducing the cellulose or cellulose derivative into the composition in granular form, and enclosing the composition in the water insoluble pouch. 15 . (canceled) 16 . The nicotine oral delivery product according to claim 2 , wherein the cellulose derivative is sodium carboxymethylcellulose.
Assignees
Inventors
Classifications
Nicotine; Derivatives thereof · CPC title
Psychostimulants, e.g. nicotine, cocaine · CPC title
Cellulose; Derivatives thereof · CPC title
having only oxygen as hetero atoms · CPC title
Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2023180817A1 cover?
- A nicotine oral delivery product includes a composition enclosed in a water insoluble pouch, wherein the pouch is permeable for saliva and dissolved compounds of the composition, the composition including a source of nicotine and a cellulose or cellulose derivative, wherein the cellulose or cellulose derivative is in granular form. A method of making the nicotine oral delivery product is also p…
- Who is the assignee on this patent?
- Jt Int Sa
- What technology area does this patent fall under?
- Primary CPC classification A24B15/16. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Jun 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).